Chlorine in PDB 7ndo: Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene
Protein crystallography data
The structure of Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene, PDB code: 7ndo
was solved by
M.Kriegel,
Y.A.Muller,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.80 /
1.60
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
48.581,
51.787,
57.513,
97.84,
113.52,
110.42
|
R / Rfree (%)
|
18.5 /
19.5
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene
(pdb code 7ndo). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene, PDB code: 7ndo:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 7ndo
Go back to
Chlorine Binding Sites List in 7ndo
Chlorine binding site 1 out
of 3 in the Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl605
b:29.4
occ:1.00
|
H
|
A:TYR328
|
2.3
|
33.5
|
1.0
|
O
|
A:HOH789
|
2.9
|
19.3
|
1.0
|
HA
|
A:LEU327
|
3.1
|
33.1
|
1.0
|
HD23
|
A:LEU327
|
3.1
|
32.3
|
1.0
|
N
|
A:TYR328
|
3.1
|
27.9
|
1.0
|
HH12
|
A:ARG352
|
3.2
|
32.6
|
1.0
|
HB2
|
A:TYR328
|
3.2
|
36.9
|
1.0
|
HB3
|
A:LEU327
|
3.3
|
31.2
|
1.0
|
HH11
|
A:ARG352
|
3.4
|
32.6
|
1.0
|
NH1
|
A:ARG352
|
3.6
|
27.2
|
1.0
|
O
|
A:HOH802
|
3.7
|
56.4
|
1.0
|
CA
|
A:LEU327
|
3.8
|
27.6
|
1.0
|
HD1
|
A:TYR328
|
3.8
|
38.7
|
1.0
|
CB
|
A:LEU327
|
3.9
|
26.0
|
1.0
|
C
|
A:LEU327
|
4.0
|
27.4
|
1.0
|
CD2
|
A:LEU327
|
4.0
|
26.9
|
1.0
|
CB
|
A:TYR328
|
4.0
|
30.8
|
1.0
|
O
|
A:TYR328
|
4.0
|
31.8
|
1.0
|
CA
|
A:TYR328
|
4.0
|
29.2
|
1.0
|
HD21
|
A:LEU327
|
4.1
|
32.3
|
1.0
|
C
|
A:TYR328
|
4.5
|
29.1
|
1.0
|
CG
|
A:LEU327
|
4.5
|
28.5
|
1.0
|
CD1
|
A:TYR328
|
4.6
|
32.3
|
1.0
|
HD13
|
A:LEU327
|
4.6
|
36.0
|
1.0
|
HD22
|
A:LEU327
|
4.7
|
32.3
|
1.0
|
HB3
|
A:TYR328
|
4.7
|
36.9
|
1.0
|
HB2
|
A:LEU327
|
4.7
|
31.2
|
1.0
|
CG
|
A:TYR328
|
4.8
|
32.0
|
1.0
|
CZ
|
A:ARG352
|
4.9
|
27.9
|
1.0
|
HA
|
A:TYR328
|
4.9
|
35.0
|
1.0
|
HD2
|
A:ARG352
|
5.0
|
35.8
|
1.0
|
O
|
A:ILE326
|
5.0
|
30.7
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 7ndo
Go back to
Chlorine Binding Sites List in 7ndo
Chlorine binding site 2 out
of 3 in the Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl606
b:26.6
occ:1.00
|
HE2
|
A:HIS356
|
2.2
|
30.3
|
1.0
|
NE2
|
A:HIS356
|
3.0
|
25.3
|
1.0
|
O
|
A:HOH755
|
3.0
|
29.7
|
1.0
|
O
|
A:HOH789
|
3.0
|
19.3
|
1.0
|
HD22
|
A:LEU327
|
3.7
|
32.3
|
1.0
|
HB3
|
A:ARG352
|
3.8
|
32.8
|
1.0
|
HD13
|
A:LEU327
|
3.9
|
36.0
|
1.0
|
HD23
|
A:LEU327
|
3.9
|
32.3
|
1.0
|
CD2
|
A:HIS356
|
3.9
|
24.3
|
1.0
|
CE1
|
A:HIS356
|
3.9
|
25.8
|
1.0
|
HD2
|
A:HIS356
|
4.0
|
29.2
|
1.0
|
HD2
|
A:ARG352
|
4.0
|
35.8
|
1.0
|
HE1
|
A:HIS356
|
4.0
|
30.9
|
1.0
|
HD11
|
A:LEU327
|
4.1
|
36.0
|
1.0
|
CD2
|
A:LEU327
|
4.3
|
26.9
|
1.0
|
CD1
|
A:LEU327
|
4.4
|
30.0
|
1.0
|
HG2
|
A:ARG352
|
4.4
|
35.9
|
1.0
|
HH11
|
A:ARG352
|
4.6
|
32.6
|
1.0
|
CB
|
A:ARG352
|
4.7
|
27.4
|
1.0
|
CD
|
A:ARG352
|
4.8
|
29.9
|
1.0
|
O
|
A:ARG352
|
4.8
|
28.9
|
1.0
|
CG
|
A:ARG352
|
4.8
|
29.9
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 7ndo
Go back to
Chlorine Binding Sites List in 7ndo
Chlorine binding site 3 out
of 3 in the Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Er-Prs*(-) (L536S, L372R) in Complex with Raloxifene within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl607
b:66.4
occ:1.00
|
HG
|
A:SER493
|
3.4
|
55.6
|
1.0
|
OE2
|
A:GLU444
|
3.4
|
32.5
|
1.0
|
HB2
|
A:SER493
|
3.5
|
56.1
|
1.0
|
HE2
|
A:TYR489
|
3.6
|
45.4
|
1.0
|
HD13
|
A:LEU495
|
3.6
|
57.6
|
1.0
|
HB3
|
A:SER493
|
3.6
|
56.1
|
1.0
|
HE
|
A:ARG503
|
3.7
|
42.4
|
1.0
|
HG
|
A:LEU495
|
3.8
|
59.0
|
1.0
|
HA
|
A:MET490
|
3.9
|
44.3
|
1.0
|
CB
|
A:SER493
|
3.9
|
46.8
|
1.0
|
HG2
|
A:MET490
|
3.9
|
43.0
|
1.0
|
NE
|
A:ARG503
|
3.9
|
35.4
|
1.0
|
O
|
A:HOH754
|
3.9
|
44.7
|
1.0
|
OG
|
A:SER493
|
4.0
|
46.3
|
1.0
|
HD3
|
A:ARG503
|
4.1
|
39.0
|
1.0
|
HG3
|
A:GLN441
|
4.1
|
45.9
|
1.0
|
CD
|
A:GLU444
|
4.2
|
33.7
|
1.0
|
CE2
|
A:TYR489
|
4.2
|
37.9
|
1.0
|
HG2
|
A:GLN441
|
4.3
|
45.9
|
1.0
|
HD22
|
A:LEU495
|
4.3
|
64.4
|
1.0
|
CD1
|
A:LEU495
|
4.3
|
48.0
|
1.0
|
HH21
|
A:ARG503
|
4.3
|
43.2
|
1.0
|
CZ
|
A:ARG503
|
4.3
|
37.6
|
1.0
|
HD11
|
A:LEU495
|
4.4
|
57.6
|
1.0
|
HD2
|
A:ARG503
|
4.4
|
39.0
|
1.0
|
CD
|
A:ARG503
|
4.4
|
32.5
|
1.0
|
CG
|
A:LEU495
|
4.4
|
49.1
|
1.0
|
NH2
|
A:ARG503
|
4.5
|
36.0
|
1.0
|
OE1
|
A:GLU444
|
4.5
|
31.9
|
1.0
|
HD2
|
A:TYR489
|
4.6
|
42.0
|
1.0
|
CG
|
A:GLN441
|
4.7
|
38.3
|
1.0
|
CA
|
A:MET490
|
4.8
|
36.9
|
1.0
|
CD2
|
A:TYR489
|
4.8
|
35.0
|
1.0
|
CG
|
A:MET490
|
4.8
|
35.9
|
1.0
|
CD2
|
A:LEU495
|
4.8
|
53.6
|
1.0
|
HB3
|
A:MET490
|
4.9
|
43.2
|
1.0
|
|
Reference:
M.Kriegel,
H.J.Wiederanders,
S.Alkhashrom,
J.Eichler,
Y.A.Muller.
A Pross-Designed Extensively Mutated Estrogen Receptor Alpha Variant Displays Enhanced Thermal Stability While Retaining Native Allosteric Regulation and Structure. Sci Rep V. 11 10509 2021.
ISSN: ESSN 2045-2322
PubMed: 34006920
DOI: 10.1038/S41598-021-89785-1
Page generated: Tue Jul 30 00:50:14 2024
|